Form 8-K - Current report:
SEC Accession No. 0001193805-21-000608
Filing Date
2021-05-06
Accepted
2021-05-06 08:16:00
Documents
14
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e620558_8k-immunic.htm   iXBRL 8-K 21115
2 e620558_ex99-1.htm EX-99.1 64868
3 GRAPHIC logo.jpg GRAPHIC 6063
  Complete submission text file 0001193805-21-000608.txt   280121

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA imux-20210506.xsd EX-101.SCH 3059
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE imux-20210506_lab.xml EX-101.LAB 34238
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imux-20210506_pre.xml EX-101.PRE 22381
7 EXTRACTED XBRL INSTANCE DOCUMENT e620558_8k-immunic_htm.xml XML 3695
Mailing Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152 49 89 250079460
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 21895904
SIC: 2834 Pharmaceutical Preparations